rss
Heart 2009;95:721-727 doi:10.1136/hrt.2008.152835
  • Original article
  • Acute coronary syndromes

Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial

  1. L G Mellbin1,
  2. K Malmberg1,
  3. A Waldenström2,
  4. H Wedel3,
  5. L Rydén1,
  6. for the DIGAMI 2 investigators
  1. 1
    Karolinska Institutet, Stockholm, Sweden
  2. 2
    University Hospital, Umeå, Sweden
  3. 3
    Nordic School of Public Health, Göteborg, Sweden
  1. Dr Linda G Mellbin, Cardiology Unit, Institution of Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden; linda.mellbin{at}karolinska.se
  • Accepted 21 October 2008
  • Published Online First 24 November 2008

Abstract

Objective: To explore if hypoglycaemic episodes during hospitalisation influence the subsequent prognosis in patients with diabetes and acute myocardial infarction.

Design, setting and patients: Within the framework of the clinical trial DIGAMI 2 hypoglycaemic episodes (blood glucose <3.0 mmol/l with or without symptoms) were recorded in 1253 patients (mean age 68 years; 67% males) with type 2 diabetes and myocardial infarction. The patients were followed during a median of 2.1 years. A total of 947 patients were randomised to an initial insulin infusion while 306 received routinely used glucose lowering therapy.

Main outcome measures: Unadjusted and adjusted (age, sex, smoking, previous infarction, heart failure, renal function, diabetes duration, coronary interventions, pharmacological treatment and B-glucose at hospital admission) hazard ratios (HR) and 95% confidence intervals (CI) for total mortality and cardiovascular events (death, re-infarction or stroke) were related to hypoglycaemic episodes during the index hospitalisation.

Results: During the first 24 hours hypoglycaemic episodes were noted in 111 (12%) insulin-treated (symptomatic 23%) and three (1.0%) routinely treated patients (symptomatic 33%). Symptomatic hypoglycaemia related to mortality (unadjusted HR 1.99; 95% CI 1.20 to 3.29; p = 0.0074) but this difference disappeared following adjustment (HR 1.09; 95% CI 0.64 to 1.87; p = 0.7403). Body weight (OR 0.97; 95% CI 0.95 to 0.98; p<0.0001) and diabetes duration (OR 1.03; 95% CI 1.01 to 1.05; p = 0.0085) were independent predictors of hypoglycaemia

Conclusions: Hypoglycaemia during the initial hospitalisation was not an independent risk factor for future morbidity or mortality in patients with type 2 diabetes and myocardial infarction. Such episodes were, however, more prevalent in patients at high risk for other reasons.

Footnotes

  • Funding: Supported by the Swedish Heart-Lung Foundation, AFA Insurance and by unconditional research grants from Aventis Sweden and Novo Nordisk Denmark.

  • Competing interests: KM is professor of cardiology at Karolinska Institutet, Stockholm for 25% of his time and employed by AstraZeneca for 75%. This company has not been involved in the trial and has no interest in this paper.

Latest from Education in Heart

Latest from Education in Heart

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Heart.
View free sample issue >>

Free archive
The full back archive is now available for Heart. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.